Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,696,327
-
Share change
-
+2,359,448
-
Total reported value
-
$2,613,964,301
-
Put/Call ratio
-
306%
-
Price per share
-
$105.84
-
Number of holders
-
250
-
Value change
-
+$250,433,013
-
Number of buys
-
130
-
Number of sells
-
122
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2017
As of 31 Mar 2017,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,696,327 shares.
The largest 10 holders included
BlackRock Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LP, Knott David M, STATE STREET CORP, CARDINAL CAPITAL MANAGEMENT LLC /CT, VICTORY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, and DEUTSCHE BANK AG\.
This page lists
250
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.